HK-listed gold stocks jump as US economic fears boost bullion prices
LONDON - Legal & General (LON:LGEN) UCITS ETF PLC ("the Company") has notified shareholders of its intention to rename one of its exchange-traded funds (ETFs) to better reflect the benchmark index it tracks. The L&G Healthcare Breakthrough UCITS ETF, with ISIN IE00BK5BC677, will soon be known as the L&G Healthcare Technology & Innovation UCITS ETF.
The change is aimed at more closely aligning the fund’s name with the ROBO Global® Healthcare Technology and Innovation Index TR, which remains the fund’s benchmark index. The management strategy of the fund will not be affected by this renaming.
The update to the fund’s name is scheduled to take place on or around May 15, 2025. The Company has issued a circular to the registered shareholder, the Bank of New York Mellon (NYSE:BK) (Depository) Nominees Limited, detailing the forthcoming change. This notice has also been submitted to the National Storage Mechanism and will be available for public inspection.
Legal & General Investment Management Limited has provided contact details for further information, including a telephone number and email address. The news service of the London Stock Exchange (LON:LSEG), RNS, has disseminated this information and is authorized by the Financial Conduct Authority in the UK as a Primary Information Provider.
This announcement is based on a press release statement and aims to inform stakeholders and the wider market of the upcoming change to the ETF’s designation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.